Hemei Wang

Dr. Wang has been engaged in non-clinical safety evaluation of drugs for more than 20 years. He is familiar with GLP regulations at home and abroad and has rich experience in toxic pathology and toxicology. At present, he is also the vice chairman of the Committee of Toxic Pathology, Chinese Pharmaceutical Society, The Toxicology Committee of the Scientific Society, The Veterinary Pathology Branch of the Chinese Veterinary Medicine Association, the GLP examination expert and CDE New Drug evaluation expert of NMPA, the certified pathologist of the Chinese Veterinary Pathology Society, and the senior member of STP, ESTP and JSTP.

Dr. Wang has undertaken more than 10 national or military longitudinal research projects, published more than 50 papers, more than 80 conference abstracts at home and abroad, 6 monographs as chief translator, and 3 monographs as chief editor or co-editor. Dr. Wang has won two second prize of Military Science and Technology Progress award and one Science and Technology Progress Award of China Association of Traditional Chinese Medicine. In 2021, he was funded by Jiangsu Province “Entrepreneurship and Innovation Talents” and won the army individual Third-class merit award once.

Dr. Wang graduated from Tongji Medical College of Huazhong University of Science & Technology，earned PhD degree in Health Toxicology from Academy of Military Medical Sciences，and experienced post-doctoral research at Medical Center of Johannes Gutenberg-Universität Mainz, Germany.